Racial factors cannot explain superior Japanese outcomes in stomach cancer

Archives of Surgery

Volumn 131, Issue 2, 1996, Pages 170-175

  Hundahl, Scott A ^a   Stemmermann, Grant N ^b,c   Oishi, Andrew ^d  

^a UNIVERSITY OF HAWAII CANCER CENTER   (United States)

^b UNIVERSITY OF CINCINNATI   (United States)

^c KUAKINI MEDICAL CENTER   (United States)

^d MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; BURSECTOMY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; GASTRECTOMY; GEOGRAPHIC DISTRIBUTION; HUMAN; JAPAN; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RACE DIFFERENCE; RETROSPECTIVE STUDY; STOMACH ADENOCARCINOMA; TREATMENT OUTCOME; UNITED STATES;

EID: 0030020641     PISSN: 00040010     EISSN: None     Source Type: Journal    
DOI: 10.1001/archsurg.1996.01430140060016     Document Type: Article

References (48)

1. American Joint Committee on Cancer Manual For Staging Of Cancer 4th ed. Philadelphia, Pa. JB Lippincott Co; 1992:65.
2. Wanebo HJ, Kennedy BJ, Chmiel J, et al. Cancer of the stomach: a patient care study by the American College of Surgeons. Ann Surg. 1993,218:583-592.
3. Maruyama K. Surgical Treatment and End Results of Gastric Cancer. Tokyo, Japan National Cancer Center Press, 1987.
4. Miwa K and the Japanese Research Society for Gastric Cancer. Evaluation of the TNM classification of stomach cancer and proposal for its rational stage grouping. Jpn J Clin Oncol. 1934;14:385-410.
5. Nakajima T, Nishi M, Kajitani T. Improvement in treatment results of gastric cancer with surgery and chemotherapy. Semin Surg Oncol. 1991;7:365-372.
6. Adam YG, Efron G. Trends and controversies in the management of carcinoma of the stomach Surg Gynecol Obstet. 1989;169:371-385.
7. Cady B, Rossi RL, Silverman ML, Piccione W, Heck T Gastric adenocarcinoma: a disease in transition Arch Surg 1989,124:303-308.
8. Fielding JWL. Gastric cancer: different diseases. Br J Surg. 1989,76:1227
9. Steele RJC, Chung SCS, Li AKC, Crofts TJ. Hepatic metastases in Hong Kong Chinese: evidence for an East-West difference in gastric cancer. Ann R Coll Surg Engl. 1987;69:60-63
10. Milewski PJ, Bancewicz J. Improving the results of treating gastric cancer. BMJ. 1989;299:278-279.
11. Bunt AMG, Hermans J, Smit VTHBM, Van de Velde CJH, Fleuren GJ, Brujin JA. Surgical/pathologic stage migration confounds comparisons of gastric cancer survival rates between Japan and Western countries. J Clin Oncol. 1995; 13:19-25.
12. Brennan MF Radical surgery for gastric cancer. Cancer 1989;64:2063
13. Feinstein AR, Sosin DM, Wells CK The Will Rogers phenomenon: stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. N Engl J Med. 1985,312:1604-1608.
14. Bodner BE Will Rogers and gastric carcinoma. Arch Surg. 1988;123.1023
15. Douglas HO Jr. R2 dissection in the treatment of gastric malignancy. Surg Oncol Clin North Am. 1993,2:413-431
16. Bonenkamp JJ, Van de Velde CJH, Kampschoer GHM, et al. Comparison of factors influencing the prognosis of Japanese, German, and Dutch gastric cancer patients World J Surg 1993;17:410-415.
17. Cuschieri A. Gastrectomy for gastric cancer: definitions and objectives. Br J Surg. 1986,73:513-514.
18. Siewert JR, Bottcher K, Roder JD Prognostic relevance of systematic lymph node dissection in gastric carcinoma. Br J Surg. 1993;80:1015-1018.
19. American Joint Committee on Cancer. Manual For Staging of Cancer 3rd ed Philadelphia, Pa: JB Lippincott Co, 1988:69-74
20. Maruyama K, Okabayashi K, Kinoshita T. Progress in gastric cancer surgery in Japan and its limits of radicality. World J Surg. 1987;11:418-425.
21. Stemmermann GN, Brown C. A survival study of the intestinal and diffuse types of gastric carcinoma Cancer 1974,33 1190-1195.
22. Shiu MH, Moore E, Sanders M, et al. Influence of the extent of resection on survival after curative treatment of gastric carcinoma a retrospective multivariate analysis Arch Surg. 1987;122 1347-1351
23. Rohde H, Bauer P, Stutzer H, Heitmann K, Gebbensleben B, and the German Gastric Cancer Study Group. Proximal compared with distal adenocarcinoma of the stomach. differences and consequences. Br J Surg. 1991,78:1242-1248.
24. Maruyama K The most important prognostic factors for gastric cancer patients Scand J Gastroenterol Suppl. 1987,133:63-68.
25. Maruyama K, Gunven P, Okabayashi K, Sasako M, Kinoshita T. Lymph node metastases of gastric cancer. Ann Surg 1989;210:596-602.
26. Japanese Research Society for Gastric Cancer Japanese Classification of Gastric Carcinoma 1st English ed Tokyo, Japan: Kanehara & Co. 1995: 15.39-65.
27. MacDonald I, Kotin P Biologic determinism in gastric carcinoma as a limiting factor of curability Surg Gynecol Obstet 1954,98:148-152.
28. Inamdar NV, Levin B. The epidemiology and causes of gastric cancer. Surg Oncol Clin North Am. 1993;2:333-345.
29. Correa P, Haensel W, Cuello C, et al Gastric precancerous process in a high risk population: cross-sectional studies. Cancer Res 1990;50.4731-4736.
30. Correa P, Haensel W, Cuello C, et al. Gastric precancerous process in a high risk population. cohort follow-up Cancer Res 1990;50:4737-4740
31. Aoki K. Epidemiology of stomach cancer In: Nishi M, Ichikawa H, Nakajima K, Maruyama K, Tahara E, eds Gastric Cancer Mew York. NY: Springer-Verlag; 1993:2-15
32. Correa P, Sasano N, Stemmermann G, Haenszel W. Pathology of gastric carcinoma in Japanese populations comparison between Miyagi Prefecture, Japan, and Hawaii. J Natl Cancer Inst 1973;51 1449-1459.
33. Kampschoer GHM, Nakajima T, Van de Velde CJH. Changing patterns in gastric adenocarcinoma. Br J Surg. 1989,76 914-916.
34. Hundahl SA, Nakasone P, Masui E Ethnic variation in the results of cancer treatment In. Hundahl SA, ed. The Queen's Medical Center Cancer Institute. 1990 Annual Report Honolulu, Hawair The Queen's Medical Center; 1991:12-14
35. Stemmermann G, Heffelfinger SC, Noffsinger A, Hui YZ, Miller MA, Fenoglio-Preiser CM. The molecular biology of esophageal and gastric cancer and their precursors Hum Pathol. 1994;25 968-981
36. Katoh M, Terada M Oncogenes and tumor suppressor genes. In. Nishi M, Ichikawa H, Nakajima K, Maruyama K, Tahara E, eds Gastric Cancer. New York. NY: Springer-Verlag, 1993 196-208.
37. Hundahl SA. Gastric cancer nodal metastases: biologic and therapeutic significance. Surg Oncol Clin North Am. In press.
38. Kodama Y, Sugimachi K, Soejima K, Matsusaka T Inokuchi K. Evaluation of extensive lymph node dissection for carcinoma of the stomach. World J Surg. 1981;5 241-248
39. Dent DM, Madden MV, Price SK Randomized comparison of R1 and R2 gastrectomy for gastric carcinoma Br J Surg 1988;75:110-112.
40. Craven J. End results of surgical treatment British experience. In: Nishi M, Ichikawa H, Nakajima T, Maruyama K, Tahara E, eds. Gastric Cancer. New York, NY Springer-Verlag, 1993:341-348.
41. Bunt AMG, Hermans J, Boon MC, et al Evaluation of the extent of lympnadenectomy in a randomized trial of Western- versus Japanese-type surgery in gastric cancer J Clin Oncol 1994;12 417-422
42. DaSilva F, Fielding JWL, Craven J MRC trial of gastric cancer: morbidity and mortality after R-1 and R-2 resections Br J Surg. 1991;78:1501.
43. Bonenkamp JJ, Songun I, Hermans J, et al. Randomised comparison of morbidity after D1 and D2 dissection for gastric cancer in 996 Dutch patients. Lancet. 1995,345:745-748.
44. Fayers PM, Cushieri A, Joypaul V, and the British Gastric Cancer Study Group. D-1 versus D-2 surgery for gastric cancer morbidity and postoperative mortality in the UK MRC randomized trial. Abstract P-3-1A In: First International Gastric Cancer Abstracts, Kyoto, Japan. March 29-April 1, 1995:9.
45. Japanese Research Society for Gastric Cancer and Miwa Registry Institute For Gastric Cancer. Japan 1979-1382: Treatment Results of Gastric Carcinoma Tokyo, Japan: Mitamura Press, 1995.
46. Gouzi JL, Huguier M, Fagniez PL, et al Total versus subtotal gastrectomy for adenocarcinoma of the gastric antrum. a French prospective controlled study. Ann Surg. 1989;209.162-166.
47. Robertson CS, Chung SCS, Woods SDS, et al. A prospective, randomized trial comparing R1 subtotal gastrectomy with R3 total gastrectomy for antral cancer. Ann Surg. 1994,220:176-182.
48. Maruyama K, Sasako M, Kinoshita T, Okajimaa K. Effectiveness of systematic lymph node dissection in gastric cancer surgery. In: Nishi M, Ichikawa H, Nakajima T, Maruyama K, Tahara E, eds. Gastric Cancer. Mew York, NY: Springer-Verlag; 1993 293-305.